BioSpace

AstraZeneca employs $1.5B cost savings to reinvest back into growth

“You don't spend one and a half billion dollars without creating jobs,” AstraZeneca CEO Pascal Soriot said as the pharma announced a new cost savings program alongside third quarter earnings.

By BioSpace

1 min read
AstraZeneca employs $1.5B cost savings to reinvest back into growth
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights